Together, the transcriptome analyses confirmed the neuronal fate commitment during early expression of Neurog2, and suggested divergent molecular mechanisms between Neurog2 and Ascl1 in converting GBM cells into neurons. The gene discussed is NEUROG2; the disease is glioblastoma.